Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
This tag curates FDA-related news and analysis to show how agency actions may affect your investments and costs. Learn what to watch, including drug reviews and biotech moves.
11 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
The FDA confirms a national shortage of needles used detect breast after a recall. Hospitals warn the gap could delay...
The FDA recently approved fruit-flavored e-cigarettes, prompting scrutiny from health advocates and investors. A new ...
Regulators warn of a loophole that allows new chemicals to enter foods and supplements without premarket approval. Th...
A six-page FDA memo quietly opens the door for certain nicotine products to reach the market before complete regulato...
An FDA leadership shakeup deepens as Tracy Hoeg publicly says she was fired, prompting questions about regulatory dir...
Rising internal strife and political pressure push the FDA toward leadership change, with markets watching how the ag...
A nationwide recall has been issued for nearly 90,000 bottles children's ibuprofen after reports of contamination. Fa...
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...